Document Page: First | Prev | Next | All | Image | This Release | Search

File: 123096_sep96_decls7_0008.txt
Page: 0008
Total Pages: 11

Subject: PREVENTION AND TREATMENT OF NERVE AGENT POISONING               

Unit: VAR. BUMED  

Parent Organization: BUMED       

Box  ID: BX303902

Folder Title: PREVENTION AND TREATMENT OF NERVE AGENT POISONING                                               

Document Number:          1

Folder Seq  #:         14




                                                                           UNCLASSIFIED
               FM$-285tNAVMED P-5041/AFM 160-11

               dostigmine bromide tablets (21 total) which are                           ing the NAPP and safeguarding it against loss.
               packaged in a blister pack. Each blister pack                             Service members will secure the blister pack in the
               (NAPP) contains enough tablets for 7 days (1 taken                        sleeve or breast pocket of the chemical protective
               every 8 hours).                                                           ensemble (or in another part of the ensemble, as
                                                                                         directed by local standing operating procedure
                                                                                         (SOP)).
                                                  MINE PRMFATMEI                                                     NOTE
                                                                                               In conjunction with the NAPP, service
                                            (KAPP)
                                            "EN ORDERED By YOUA 001                            members should be issued an additional
                                                                                               M268AIo Sk-m Deconta                     g- Kit--tfig
                                               THE STATED DOSE                                 G-1) which will be carried on the load-
                                            MINE BROMIDE X 21 TABLETS                          bearing equipment suspenders.
                                                                                           c. Orders to start taking the NAPP will be issued
of com-
                                                                                         mand.
                                                                                           d- Resupply will be provided by Combat, Combat
                                                                                         Support, and Combat Service Support Units.
                                                                                         2-17. Effects of Pyridostigmine Bromide
                                                                                           a. Pyridostigmine bromide protects an enzyme
                                                                                         (known as acetylcholinesterase) in the body from
                                                                                         the action of nerve agent& Muscles function as a
                                                                                         result of nerve impulses and the release of specific
                        SAM;-LE PYRIDOS'NGMINE BROMIDE TABLETS.                          -chemical substances. A chemical transmitter, ace-
                                                                                         tylcholine, acts at the neuromuscular junction
               Figure2-2.NvwAi7i7uPymdostigmimPreireat,.te,,ITabletSeL                   (where the nerve interfaces with the muscle) (fig
                                                                                         2-3). When a nerve impulse reaches the neuromus-
                  b. Service members are initially issued I NAPP                         culir junction, acefylcholiiie'(the che-mical trans-
               when the chemical protective ensemble is expected                         mitter) is released, thereby causing the muscle to
               to be opened for use. They are responsible !or carry-                     contract. The enzyme, acetylcholinesterasd, stops

                                      NEUROMC)SCULAR
                                                       JUNCTION




                                          NERVE


                                                                                               d      MUSCL6"



                                   ELECTRICAL NERVE lq,


                                NERVE IMPULSE RELEASES
                                       ACETYLCHOLINE
                                                                                               E CONTRACTS AND ACETYLCHOLINE
                               (CHEMICAL TRANSMITTER)                                IS INACNVATED By ACETYLCHOLINESTERASE


                                                      ACETYLCHOLINE CROSSES THE NEUROMUSCULAR
                                                         JUNCTION CAUSING MUSCLE CONTRACTION


                                                  Figure t-,q. S@atic nftrmus@rjuncti" (ml to scale).

             2-16
                                                                             UNCLASSIFIED,

Document Page: First | Prev | Next | All | Image | This Release | Search


Document 11 f:/Week-44/BX303902/PREVENTION AND TREATMENT OF NERVE AGENT POISONING/prevention and treatment of nerve agent poisonin:1217960956196
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-44
Box ID = BX303902
Unit = VAR. BUMED
Parent Organization = BUMED
Folder Title = PREVENTION AND TREATMENT OF NERVE AGENT POISONING
Folder Seq # = 14
Subject = PREVENTION AND TREATMENT OF NERVE AGENT POISONIN
Document Seq # = 1
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 17-DEC-1996